Global Digital Pathology Market Outlook to 2024 - M&A, Technological Development, and Geographical Expansion are the Growth Strategies Being Adopted by Key Players - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 2, 2019--The “Global Digital Pathology Market (2018 - 2024)” report has been added to ResearchAndMarkets.com’s offering.
The increasing number of teleconsultations, rising adoption of digital pathology to enhance lab efficiency, and increasing application in drug discovery and companion diagnostics are driving the global digital pathology market. Moreover, the investment in laboratory expansion and market penetration of key manufacturers are also likely to propel the market growth.
The aim of teleconsultation is to omit geographical and functional distance between two or more geographically separated healthcare providers. It is defined as the consultation by remote telecommunications, primarily for the diagnosis or treatment of a patient at sites that are distant from the patient or primary physician.
Teleconsultation services are being implemented by several hospitals, primary healthcare physicians, private medical practices, and other medical units. Thus, it has proven to be feasible and effective, to potentially reduce costs, provide organizational benefits, and improve patient’s satisfaction.
The use of digital pathology in disease diagnosis is also increasing, due to the integration of digital pathology with digital tools, barcoding, specimen tracking, and digital dictation, which improvise the safety, quality, and efficiency of disease diagnoses in pathology laboratories.
The market is also expected to be driven by the increasing adoption of telepathology, rising investment in healthcare in developed countries, market penetration of key manufacturers in the developing region, and an increasing focus on drug discovery.
Key Market Trends
Disease Diagnosis is the Fastest Segment by Application that is Expected to Grow during the Forecast Period
For the diagnosis of diseases, digital pathology encompasses different technologies, which include laboratory management systems, digital dictation, dashboards and workflow management, digital image analysis, electronic specimen labelling and tracking, and synoptic reporting tools. Therefore, the integration of digital pathology, along with these digital tools, barcoding, specimen tracking, and digital dictation, improvise the safety, quality, and efficiency of disease diagnoses in pathology laboratories. Hence, owing to the advantages of using digital pathology for disease diagnoses, the market is expected to grow at a good pace during the forecast period.
Asia-Pacific is the Fastest-growing Region and it is Expected to Follow the Same Trend over the Forecast Period
The Asia-Pacific digital pathology market is anticipated to exhibit the fastest CAGR during the forecast period, due to the proliferation of advanced imaging modalities in emerging economies, growing investments in medical field, and presence of untapped opportunities. Thus, the presence of a large target patient population and booming healthcare industry is encouraging the growth of the regional market.
North America is expected to dominate the overall market throughout the forecast period. The presence of high per capita healthcare expenditure, increasing investment from key players, and the well-established IT and healthcare infrastructure are some of the factors contributing to the growth of the market in the region.
The key players in the global market are adopting strategies, such as mergers and acquisitions, technological development, and geographical expansion, in order to capture a significant position. Several manufacturers are focusing on developing digital pathology scanners with high throughput, improved resolution, high magnification, and high-end microscopes with automated scanning, all of which are expected to drive the market growth during the forecast period.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Number of Tele-consultations
4.2.2 Rising Adoption of Digital Pathology to Enhance Lab Efficiency
4.2.3 Increasing Application in Drug Discovery and Companion Diagnostics
4.3 Market Restraints
4.3.1 Stringent Regulatory Concerns for Primary Diagnosis
4.3.2 Lack of Standard Guidelines for Digital Pathology
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Product
5.1.3 Storage Systems
5.1.4 Other Products
5.2 By Application
5.2.1 Disease Diagnosis
5.2.2 Drug Discovery
5.2.3 Education and Training
5.3 By End User
5.3.1 Pharmaceutical, Biotechnology, Companies and CROs
5.3.2 Hospital and Reference Laboratories
5.3.3 Other End Users
5.4.1 North America
5.4.4 Middle East & Africa
5.4.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3DHistech Ltd.
6.1.2 Definiens AG
6.1.3 Hamamatsu Photonics K.K.
6.1.4 Leica Biosystems Nussloch GmbH
6.1.5 Mikroscan Technologies Inc.
6.1.6 Nikon Corporation
6.1.7 Olympus Corporation
6.1.8 Koninklijke Philips N.V.
6.1.9 Ventana Medical Systems Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/research/qfnzm9/global_digital?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190402005571/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Medical Imaging
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/02/2019 07:47 AM/DISC: 04/02/2019 07:47 AM